Regulation of coronary arterial bk channels by caveolae-mediated angiotensin II signaling in diabetes mellitus

Circulation Research

Volumn 106, Issue 6, 2010, Pages 1164-1173

  Lu, Tong ^a   Zhang, Dai Min ^a   Wang, Xiao Li ^a   He, Tongrong ^a   Wang, Ru Xing ^b   Chai, Qiang ^a   Katusic, Zvonimir S ^a   Lee, Hon Chi ^a  

^a MAYO CLINIC   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; BK channel; Caveolin 1; Coronary smooth muscle cells; Reactive oxygen species

Indexed keywords

ANGIOTENSIN II; APELIN RECEPTOR; CALCIUM ACTIVATED POTASSIUM CHANNEL; CAVEOLIN 1; GUANINE NUCLEOTIDE BINDING PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CAVEOLA; CELL MEMBRANE; CONTROLLED STUDY; CORONARY ARTERY; DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; ONCOGENE SRC; OXIDATION REDUCTION REACTION; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SMOOTH MUSCLE FIBER; STREPTOZOCIN DIABETES; UPREGULATION;

ANGIOTENSIN II; ANIMALS; CAVEOLAE; CAVEOLIN 1; CORONARY VESSELS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ENZYME INHIBITORS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; MEMBRANE POTENTIALS; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; NADH, NADPH OXIDOREDUCTASES; OXIDATION-REDUCTION; PATCH-CLAMP TECHNIQUES; PHOSPHORYLATION; POTASSIUM; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-TYROSINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION; TIME FACTORS; VASOCONSTRICTION;

EID: 77951017344     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.209767     Document Type: Article

References (30)

1. Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, Umemura T, Nakamura S, Yoshida M. Diabetes mellitus is associated with insufficient microvascular reperfusion following revascularization for anterior acute myocardial infarction. Intern Med. 2003;42: 554-559. (Pubitemid 36926829)
2. + channels by high glucose. Circ Res. 2006;99:607-616. (Pubitemid 44401452)
3. + channels in rat cerebral artery smooth muscle cells. Am J Physiol. 2000;278: H1883-H1890. (Pubitemid 30439200)
4. Pieper GM. Superoxide dismutase plus catalase improves post-ischaemic recovery in the diabetic heart. Cardiovasc Res. 1988;22:916-926.
5. + channels in coronary arterial smooth muscle cells in Zucker Diabetic Fatty rats. Diabetes. 2005;54: 2155-2163. (Pubitemid 40911279)
6. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, Griendling KK. Novel gp91(phox) homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res. 2001;88: 888-894. (Pubitemid 32441466)
7. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007;292:C82-C97.
8. Sumimoto H, Miyano K, Takeya R. Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun. 2005;338:677-686. (Pubitemid 41540615)
9. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci. 2003;24:471-478. (Pubitemid 37088172)
10. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002;105:1656-1662. (Pubitemid 34298608)
11. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52:415-472.
12. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52:639-672.
13. Ushio-Fukai M, Alexander RW. Caveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle. Hypertension. 2006;48: 797-803. (Pubitemid 44610981)
14. Basset O, Deffert C, Foti M, Bedard K, Jaquet V, Ogier-Denis E, Krause KH. NAD(P)H oxidase 1 deficiency alters caveolin phosphorylation and angiotensin II receptor localization in vascular smooth muscle. Antioxid Redox Signal. 2009;11:2371-2384.
15. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscle Thromb Vacs Biol. 2004;24: 677-683. (Pubitemid 38451603)
16. Zuo L, Ushio-Fukai M, Ikeda S, Hilenski L, Patrushev N, Alexander RW. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler Thromb Vasc Biol. 2005;25:1824-1830. (Pubitemid 41243449)
17. Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, Herrmann F, Krause KH. Decreased blood pressure in NOX1-deficient mice. FEBS Lett. 2006;580:497-504. (Pubitemid 43089678)
18. Krajewska WM, Maslowska I. Caveolins: structure and function in signal transduction. Cell Mol Biol Lett. 2004;9:195-220. (Pubitemid 38902217)
19. Cohen AW, Razani B, Schubert W, Williams TM, Wang XB, Iyengar P, Brasaemle DL, Scherer PE, Lisanti MP. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes. 2004;53: 1261-1270. (Pubitemid 38569012)
20. + channels in vascular endothelial cells. J Biol Chem. 2005; 280:11656-11664. (Pubitemid 40418480)
21. Alioua A, Lu R, Kumar Y, Eghbali M, Kundu P, Toro L, Stefani E. Slo1 caveolin-binding motif, a mechanism of caveolin-1-Slo1 interaction regulating Slo1 surface expression. J Biol Chem. 2008;283: 4808-4817.
22. Lu T, Ye D, Wang X, Seubert JM, Graves JP, Bradbury JA, Zeldin DC, Lee HC. Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms. J Physiol. 2006;575:627-644. (Pubitemid 44270186)
23. Liou JY, Deng WG, Gilroy DW, Shyue SK, Wu KK. Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts. J Biol Chem. 2001;276:34975-34982. (Pubitemid 37384502)
24. Lam TY, Seto SW, Lau YM, Au LS, Kwan YW, Ngai SM, Tsui KW. Impairment of the vascular relaxation and differential expression of caveolin-1 of the aorta of diabetic +db/+db mice. Eur J Pharmacol. 2006;546:134-141.
25. Connelly KA, Boyle AJ, Kelly DJ. Angiotensin II and the cardiac complications of diabetes mellitus. Curr Pharm Des. 2007;13: 2721-2729.
26. Yoshimoto T, Fukai N, Sato R, Sugiyama T, Ozawa N, Shichiri M, Hirata Y. Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells. Endocrinology. 2004;145:3331-3337.
27. Aslan M, Ozben T. Oxidants in receptor tyrosine kinase signal trans-duction pathways. Antioxid Redox Signal. 2003;5:781-788.
28. Herrero MB, de Lamirande E, Gagnon C. Tyrosine nitration in human spermatozoa: a physiological function of peroxynitrite, the reaction product of nitric oxide and superoxide. Mol Hum Reprod. 2001;7:913-921.
29. + channel activity in smooth muscle of human coronary arterioles. Circ Res. 2002;91:1070-1076.
30. + channels as a new mechanism of agonist-induced vasoconstriction. Proc Natl Acad Sci USA. 2002;99:14560-14565.